EUVIMEDEUVIMED entdecken
Crossref

Ganoderma Microsporum immunomodulatory protein suppresses osteosarcoma growth through redox imbalance and ER stress-driven apoptosis

Ying-Sui Sun, Chi-Jen Chang, Tsung-Ming Chang, Peng Chen, Ju-Fang Liu

Bioorganic Chemistry · 2026-08 · 177 · 109909

DOI: 10.1016/j.bioorg.2026.109909 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-08. Verfasst von Ying-Sui Sun und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan. Hauptthemen laut MEDLINE: Osteosarcoma, Apoptosis, Ganoderma, Antineoplastic Agents. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Science and Technology Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is an aggressive bone malignancy with limited therapeutic advances and persistent chemoresistance, highlighting the need for safer and more effective treatments. Ganoderma microsporum immunomodulatory protein (GMI) is a fungal-derived bioactive molecule with reported antitumor activity, yet its effects in OS remain unknown. Here, we investigated the anticancer potential and mechanisms of GMI in osteosarcoma. GMI selectively reduced the viability of HOS and U2OS cells while exhibiting low toxicity toward normal osteoblasts. GMI induced morphological alterations, chromatin condensation, reduced colony formation, apoptosis, and G2/M arrest. RNA sequencing identified 292 upregulated and 158 downregulated genes, indicating suppression of DNA repair, proliferation, cell-cycle progression, and mitochondrial pathways, alongside activation of autophagy-related signatures. Mechanistically, GMI elevated intracellular reactive oxygen species (ROS), and N-acetylcysteine (NAC) attenuated GMI-induced apoptosis and restored viability. GMI-induced ER stress was associated with JNK activation, and sustained JNK activation disrupts the balance of BCL-2 family proteins by repressing anti-apoptotic BCL-2 and augmenting pro-apoptotic members, thereby driving mitochondria-dependent apoptosis in osteosarcoma cells. In addition, GMI treatment increases the formation of acidic vesicular organelles and autophagosome-like structures, accompanied by elevated LC3B-II and reduced p62 levels. Pharmacological blockade of autophagy using Baf A1, CQ, or 3-MA further augments GMI-induced apoptosis and exacerbates the reduction in cell viability. Finally, GMI significantly inhibited tumor growth in a xenograft model without affecting body weight. These findings identify GMI as a promising natural therapeutic candidate for osteosarcoma and warrants further preclinical and translational evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteosarcomaApoptosisGanodermaAntineoplastic AgentsEndoplasmic Reticulum StressFungal ProteinsBone NeoplasmsImmunologic FactorsHumansAnimalsCell ProliferationMiceDrug Screening Assays, AntitumorOxidation-ReductionReactive Oxygen SpeciesDose-Response Relationship, DrugStructure-Activity RelationshipMolecular Structure

Stichwörter der Autor:innen

ApoptosisEndoplasmic reticulum stressGanoderma microsporum immunomodulatory proteinOsteosarcomaReactive oxygen species

Substanzen

Antineoplastic AgentsFungal ProteinsReactive Oxygen SpeciesImmunologic Factors

Autor:innen und Institutionen

  • School of Dental Technology, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan.
  • School of Medicine, Fu Jen Catholic University, New Taipei City 242062, Taiwan; Division of Pediatric Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan.
  • Liaison Center for Innovative Dentistry, Graduate School of Dentistry, Tohoku University, Sendai, Japan.
  • School of Oral Hygiene, College of Oral Medicine, Taipei Medical University, Taipei 110301, Taiwan; Translational Medicine Center, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 111045, Taiwan; Department of Medical Resea…

Förderung

  • National Science and Technology Council

Zitieren

APA

Sun, Y. S., Chang, C. J., Chang, T. M., Chen, P., & Liu, J. F. (2026). Ganoderma Microsporum immunomodulatory protein suppresses osteosarcoma growth through redox imbalance and ER stress-driven apoptosis. Bioorganic Chemistry, 177, 109909. https://doi.org/10.1016/j.bioorg.2026.109909

Vancouver

Sun YS, Chang CJ, Chang TM, Chen P, Liu JF. Ganoderma Microsporum immunomodulatory protein suppresses osteosarcoma growth through redox imbalance and ER stress-driven apoptosis. Bioorganic Chemistry. 2026;177:109909. doi:10.1016/j.bioorg.2026.109909

BibTeX
@article{Sun2026,
  author = {Sun, Ying-Sui and Chang, Chi-Jen and Chang, Tsung-Ming and Chen, Peng and Liu, Ju-Fang},
  title = {Ganoderma Microsporum immunomodulatory protein suppresses osteosarcoma growth through redox imbalance and ER stress-driven apoptosis},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {177},
  pages = {109909},
  doi = {10.1016/j.bioorg.2026.109909}
}
Kostenlos starten →